Scholar Rock (SRRK)

• Market cap: $4.78B
• 1 day: 0.09%
• 5 days: 2.16%
• 1 month: 52.08%
• 3 months: 47.99%
• 6 months: 40.67%
• Year to date: 6.14%
• 1 year: 12.53%
• 5 years: -2.23%
• 10 years: 202.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Employees: 196